Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers.Published in:Science Translational Medicine, 2012, v. 4, n. 120, p. 1, doi. 10.1126/scitranslmed.3003316By:Katayama, Ryohei;Shaw, Alice T.;Khan, Tahsin M.;Mino-Kenudson, Mari;Solomon, Benjamin J.;Halmos, Balazs;Jessop, Nicholas A.;Wain, John C.;Alan Tien Yeo;Benes, Cyril;Drew, Lisa;Saeh, Jamal Carlos;Crosby, Katherine;Sequist, Lecia V.;Iafrate, A. John;Engelman, Jeffrey A.Publication type:Article